| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67877-704-05 | 67877-704 | HUMAN PRESCRIPTION DRUG | Droxidopa | Droxidopa | CAPSULE | ORAL | 20210219 | N/A | ANDA | ANDA213911 | Ascend Laboratories, LLC | DROXIDOPA | 100 mg/1 | 500 CAPSULE in 1 BOTTLE (67877-704-05) |
| 67877-705-90 | 67877-705 | HUMAN PRESCRIPTION DRUG | Droxidopa | Droxidopa | CAPSULE | ORAL | 20210219 | N/A | ANDA | ANDA213911 | Ascend Laboratories, LLC | DROXIDOPA | 200 mg/1 | 90 CAPSULE in 1 BOTTLE (67877-705-90) |
| 67877-706-05 | 67877-706 | HUMAN PRESCRIPTION DRUG | Droxidopa | Droxidopa | CAPSULE | ORAL | 20210219 | N/A | ANDA | ANDA213911 | Ascend Laboratories, LLC | DROXIDOPA | 300 mg/1 | 500 CAPSULE in 1 BOTTLE (67877-706-05) |
| 67877-706-90 | 67877-706 | HUMAN PRESCRIPTION DRUG | Droxidopa | Droxidopa | CAPSULE | ORAL | 20210219 | N/A | ANDA | ANDA213911 | Ascend Laboratories, LLC | DROXIDOPA | 300 mg/1 | 90 CAPSULE in 1 BOTTLE (67877-706-90) |
| 67877-705-05 | 67877-705 | HUMAN PRESCRIPTION DRUG | Droxidopa | Droxidopa | CAPSULE | ORAL | 20210219 | N/A | ANDA | ANDA213911 | Ascend Laboratories, LLC | DROXIDOPA | 200 mg/1 | 500 CAPSULE in 1 BOTTLE (67877-705-05) |
| 67877-704-90 | 67877-704 | HUMAN PRESCRIPTION DRUG | Droxidopa | Droxidopa | CAPSULE | ORAL | 20210219 | N/A | ANDA | ANDA213911 | Ascend Laboratories, LLC | DROXIDOPA | 100 mg/1 | 90 CAPSULE in 1 BOTTLE (67877-704-90) |